Comparison Overview

MAST Biosurgery

VS

BD

MAST Biosurgery

6749 Top Gun Street, Ste 108, San Diego, CA, 92121, US
Last Update: 2025-05-04 (UTC)
Between 800 and 900

Strong

Leading in the design, development, and production of bioresorbable polymer implants, and emerging new technologies for the use in variety of surgical applications within the biosurgery market. Before the advent of bioresorbable materials, the closure of soft tissue was limited to permanent materials such as nylon sutures. Advances in material sciences led to the development of bioresorbable polymer sutures that met the clinical needs of holding soft tissues together, while serving the patient's need of not remaining permanently in the body. The evolution of bioresorbable polymer technology facilitated the development of large bioresorbable polymer sheets that could span large tissue masses and subsequently hold them in place. The thin sheets facilitate the healing of larger tissue masses and virtually eliminating many adverse effects of permanent implants. Bioresorbable surgical thin sheet for soft tissue applications, made from polylactide (PLA): a copolymer of 70:30 Poly(L-lactide-co-D,L-lactide). Composed of lactic acid similar to that which occurs naturally in the human body, the copolymer maintains its strength during the healing process, and through hydrolysis slowly breaks down into lactic acid molecules. The molecules are ultimately metabolized into carbon dioxide and water and are released from the body through the lungs.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 18
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

BD

1 Becton Drive, Franklin Lakes, New Jersey, 07417, US
Last Update: 2025-03-04 (UTC)

Strong

Between 800 and 900

BD is one of the largest global medical technology companies in the world and is advancing the world of healthโ„ข by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 43,786
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
MAST Biosurgery
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/bd1.jpeg
BD
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
MAST Biosurgery
100%
Compliance Rate
0/4 Standards Verified
BD
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for MAST Biosurgery in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for BD in 2025.

Incident History โ€” MAST Biosurgery (X = Date, Y = Severity)

MAST Biosurgery cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” BD (X = Date, Y = Severity)

BD cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
MAST Biosurgery
Incidents

No Incident

https://images.rankiteo.com/companyimages/bd1.jpeg
BD
Incidents

No Incident

FAQ

Both MAST Biosurgery company and BD company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, BD company has disclosed a higher number of cyber incidents compared to MAST Biosurgery company.

In the current year, BD company and MAST Biosurgery company have not reported any cyber incidents.

Neither BD company nor MAST Biosurgery company has reported experiencing a ransomware attack publicly.

Neither BD company nor MAST Biosurgery company has reported experiencing a data breach publicly.

Neither BD company nor MAST Biosurgery company has reported experiencing targeted cyberattacks publicly.

Neither MAST Biosurgery company nor BD company has reported experiencing or disclosing vulnerabilities publicly.

BD company has more subsidiaries worldwide compared to MAST Biosurgery company.

BD company employs more people globally than MAST Biosurgery company, reflecting its scale as a Medical Equipment Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

Improper Protection Against Voltage and Clock Glitches in FPGA devices, could allow an attacker with physical access to undervolt the platform resulting in a loss of confidentiality.

Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Malicious code was inserted into the Nx (build system) package and several related plugins. The tampered package was published to the npm software registry, via a supply-chain attack. Affected versions contain code that scans the file system, collects credentials, and posts them to GitHub as a repo under user's accounts.

Risk Information
cvss3
Base: 9.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
Description

Flag Forge is a Capture The Flag (CTF) platform. In versions from 2.1.0 to before 2.3.0, the API endpoint GET /api/problems/:id returns challenge hints in plaintext within the question object, regardless of whether the user has unlocked them via point deduction. Users can view all hints for free, undermining the business logic of the platform and reducing the integrity of the challenge system. This issue has been patched in version 2.3.0.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Description

Flag Forge is a Capture The Flag (CTF) platform. In version 2.1.0, the /api/admin/assign-badge endpoint lacks proper access control, allowing any authenticated user to assign high-privilege badges (e.g., Staff) to themselves. This could lead to privilege escalation and impersonation of administrative roles. This issue has been patched in version 2.2.0.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

parse is a package designed to parse JavaScript SDK. A Prototype Pollution vulnerability in the SingleInstanceStateController.initializeState function of parse version 5.3.0 and before allows attackers to inject properties on Object.prototype via supplying a crafted payload, causing denial of service (DoS) as the minimum consequence.